|
UGCG expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.147200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.110960E-01 |
| Normal-vs-Stage2 |
5.651400E-01 |
| Normal-vs-Stage3 |
7.971400E-01 |
| Normal-vs-Stage4 |
9.284200E-01 |
| Stage1-vs-Stage2 |
4.457400E-01 |
| Stage1-vs-Stage3 |
1.949740E-02 |
| Stage1-vs-Stage4 |
7.478400E-02 |
| Stage2-vs-Stage3 |
3.646000E-01 |
| Stage2-vs-Stage4 |
5.165600E-01 |
| Stage3-vs-Stage4 |
8.785200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.480200E-01 |
| Normal-vs-AfricanAmerican |
5.554000E-01 |
| Normal-vs-Asian |
1.227170E-01 |
| Caucasian-vs-AfricanAmerican |
1.109590E-01 |
| Caucasian-vs-Asian |
1.789610E-01 |
| AfricanAmerican-vs-Asian |
4.732000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.300400E-01 |
| Normal-vs-Female |
8.977900E-02 |
| Male-vs-Female |
1.761900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.958600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.878200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.954200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.556400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.464400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.571200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.459000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.760600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.573600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.884400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.911800E-01 |
| Normal-vs-Grade 2 |
5.686400E-02 |
| Normal-vs-Grade 3 |
8.869000E-01 |
| Normal-vs-Grade 4 |
4.580400E-01 |
| Grade 1-vs-Grade 2 |
8.585200E-01 |
| Grade 1-vs-Grade 3 |
2.558200E-01 |
| Grade 1-vs-Grade 4 |
1.383840E-01 |
| Grade 2-vs-Grade 3 |
9.396600E-03 |
| Grade 2-vs-Grade 4 |
3.977100E-03 |
| Grade 3-vs-Grade 4 |
2.616400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.044360E-02 |
| Normal-vs-ccB subtype |
9.399800E-01 |
| ccA subtype-vs-ccB subtype |
8.213400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.285000E-01 |
| Normal-vs-N1 |
8.555800E-01 |
| N0-vs-N1 |
8.278600E-01 |
|
|
